ArticleClinical drug investigation2014

Younger females are at greater risk of vasodilation-related adverse symptoms caused by dihydropyridine calcium channel blockers: results of a study of 11,918 Japanese patients.

Ayami Kajiwara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.